AIM Banners_978 x 90

Behind IBM’s Autonomous Chemistry Lab

Behind IBM’s Autonomous Chemistry Lab
Image by Behind IBM’s Autonomous Chemistry Lab
With no stoppage of the COVID pandemic in the foreseeable future, drug discovery has been a critical concern for the healthcare industry. But, in reality, it takes around a decade with approximately $10 million to discover a new drug, get it tested and bring it to the market. Such a delayed process can be majorly attributed to the tedious process of repetitive experiments to bring out the drug. Thus, to omit this significant hurdle in drug discovery, IBM has launched an autonomous chemistry lab combining AI, robotics and cloud technology — RoboRXN. A cloud-based AI model, RoboRXN has been developed to perform autonomously, like a robot, using machine learning algorithms to produce chemicals and drugs in a laboratory with little to no human intervention. Not only a development like tha
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Already have an account? Sign In.

📣 Want to advertise in AIM? Book here

Picture of Sejuti Das
Sejuti Das
Sejuti currently works as Associate Editor at Analytics India Magazine (AIM). Reach out at sejuti.das@analyticsindiamag.com
Related Posts
AIM Print and TV
Don’t Miss the Next Big Shift in AI.
Get one year subscription for ₹5999
Download the easiest way to
stay informed